Jane Street’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-10,300
Closed -$318K 9923
2023
Q3
$318K Buy
+10,300
New +$355K ﹤0.01% 6981
2022
Q1
Sell
-7,300
Closed -$536K 11143
2021
Q4
$536K Buy
+7,300
New +$600K ﹤0.01% 7126

Other funds holding ASTH

Jane Street's ASTH Position: Q1 2026 in Review

Jane Street reduced its Astrana Health (ASTH) stake by 61% in Q1 2026, selling an estimated $1.22M and leaving 32,868 shares worth $806K. The position accounts for ﹤0.01% of the portfolio, ranked #6959.

Jane Street first reported a position in ASTH in Q3 2021 and has held it in 16 quarters since. The position peaked at $39M in Q3 2024. 171 funds tracked by Wall St. Rank hold ASTH as of Q1 2026.

  • Jane Street held 32,868 shares of Astrana Health worth $806K as of Q1 2026.
  • Jane Street sold 51,578 Astrana Health shares in Q1 2026, an estimated $1.22M.
  • Astrana Health made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #6959 holding.
  • Jane Street first reported a position in Astrana Health in Q3 2021 and has held it in 16 quarters since.
  • Jane Street's Astrana Health position peaked at $39M in Q3 2024.
  • 171 funds tracked by Wall St. Rank held Astrana Health as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.